{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:38:50Z","timestamp":1793104730752,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpainsymman.2026.09.035","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:15:27Z","timestamp":1790896527000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deprescribing Olanzapine After Cancer-Related Symptoms Resolve: Insights From a Two-Case Series"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-6708","authenticated-orcid":false,"given":"Magdelene Doris","family":"Amoateng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-0412","authenticated-orcid":false,"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-8675","authenticated-orcid":false,"given":"Akhila","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2026.09.035_bib0001","series-title":"The benefits of olanzapine in palliating symptoms","author":"Davis","year":"2021"},{"issue":"3","key":"10.1016\/j.jpainsymman.2026.09.035_bib0002","doi-asserted-by":"crossref","first-page":"600","DOI":"10.21037\/apm-22-1167","article-title":"Benefits and risks of off-label olanzapine use for symptom management in cancer patients\u2014a case report","volume":"12","author":"Dev","year":"2023","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.09.035_bib0003","article-title":"Olanzapine-induced hypertriglyceridemia in cancer care: a silent metabolic risk","volume":"17","author":"Kazi","year":"2025","journal-title":"Curr Probl Cancer: Case Rep"},{"issue":"5","key":"10.1016\/j.jpainsymman.2026.09.035_bib0004","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.jpainsymman.2026.09.035_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11606-014-2980-0","article-title":"The role of professional societies in limiting indication creep","volume":"30","author":"Riggs","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.jpainsymman.2026.09.035_bib0006","first-page":"2849","article-title":"Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study","volume":"27","author":"Harder","year":"2019","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.jpainsymman.2026.09.035_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.6004\/jnccn.2025.7033","article-title":"Olanzapine for anorexia in patients with incurable cancer and cachexia (OlAnCa): a double-blind, placebo-controlled, randomized clinical trial","volume":"23","author":"Othman","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jpainsymman.2026.09.035_bib0008","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.22.01997","article-title":"Randomized double-blind placebo-controlled study of Olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer","volume":"41","author":"Sandhya","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.09.035_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","volume":"101","author":"Rojo","year":"2015","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.jpainsymman.2026.09.035_bib0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004714-200108000-00003","article-title":"Novel antipsychotics and severe hyperlipidemia","volume":"21","author":"Meyer","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"11\u201312","key":"10.1016\/j.jpainsymman.2026.09.035_bib0011","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2298\/SARH1512712P","article-title":"Long-term treatment with olanzapine in hospital conditions: prevalence and predictors of the metabolic syndrome","volume":"143","author":"Popovi\u0107","year":"2015","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.jpainsymman.2026.09.035_bib0012","doi-asserted-by":"crossref","unstructured":"Consensus development conference on antipsychotic drugs and obesity and diabetes. 2004. Available fromhttp:\/\/diabetesjournals.org\/care\/articlepdf\/27\/2\/596\/661226\/zdc00204000596.pdf","DOI":"10.2337\/diacare.27.2.596"},{"issue":"1","key":"10.1016\/j.jpainsymman.2026.09.035_bib0013","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.jpainsymman.2026.09.035_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/15622975.2011.592546","article-title":"Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial","volume":"15","author":"Cordes","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.09.035_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2003.09.016","article-title":"Weight decline in patients switching from olanzapine to quetiapine","volume":"70","author":"Gupta","year":"2004","journal-title":"Schizophr Res"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426010146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426010146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:25:08Z","timestamp":1793103908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392426010146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"alternative-id":["S0885392426010146"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.09.035","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deprescribing Olanzapine After Cancer-Related Symptoms Resolve: Insights From a Two-Case Series","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}